Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression

被引：0
|
作者：
Malik, Aleena [1 ]
Jairam, Meghan P. [2 ]
Chow, Ronald [1 ,3 ]
Mirshahvalad, Seyed A. [1 ]
Veit-Haibach, Patrick [1 ]
Simone II, Charles B. [3 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[3] Mem Sloan Kettering Canc Ctr, New York Proton Ctr, New York, NY 10065 USA
来源：
FUTURE ONCOLOGY | 2023年 / 19卷 / 04期
关键词：
hepatocellular carcinoma; local control; meta-regression; radiofrequency ablation; stereotactic body radiation therapy; RADIOTHERAPY; OUTCOMES; SURVIVAL;
D O I：
10.2217/fon-2022-0893
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: The aim of this meta-regression was to assess the impact of mean/median age, mean/median tumor size, percentage of males in total sample, and total sample size on the comparative effectiveness of radiofrequency ablation (RFA) and stereotactic body radiation therapy (SBRT). Methods: Ten studies reporting on the composite outcome of overall survival and local control were included. Results: A significant relationship was found between age and overall survival at 1 and 2 for both RFA and SBRT. A significant relationship was noted also between age and local control at 1 and 2 years for RFA. Conclusion: Patients treated with SBRT had a wider range of tumor sizes and larger tumor sizes; no relationship was observed between tumor size and overall survival or local control by SBRT.
引用
收藏
页码：279 / 287
页数：9
相关论文
共 50 条
  • [21] Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma: Does Radiation Dose Make a Difference? Reply
    Rajyaguru, Devalkumar J.
    Borgert, Andrew J.
    Halfdanarson, Thorvardur R.
    Truty, Mark J.
    Kurup, A. Nicholas
    Go, Ronald S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) : 2567 - +
  • [22] A prospective, open-label, randomized, controlled trial of radiofrequency ablation versus stereotactic body radiation therapy for recurrent small hepatocellular carcinoma
    Zhang, Yaojun
    Xi, Mian
    Chen, Minshan
    Xu, Li
    Liu, Shi-Liang
    Liu, Mengzhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis
    Facciorusso, Antonio
    Chierici, Andrea
    Cincione, Ivan
    Sacco, Rodolfo
    Ramai, Daryl
    Mohan, Babu P.
    Chandan, Saurabh
    Ofosu, Andrew
    Cotsoglou, Christian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (06) : 681 - 688
  • [24] Stereotactic body radiation therapy in hepatocellular carcinoma
    Saini, Gagan
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (04) : 488 - 491
  • [25] Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
    Kittel, J.
    Balagamwala, E. H.
    Agrawal, S.
    Fung, J.
    Aucejo, F.
    Menon, K. V.
    Abdel-Wahab, M.
    Stephans, K. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E174 - E174
  • [26] Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
    Lo, Simon S.
    Dawson, Laura A.
    Kim, Edward Y.
    Mayr, Nina A.
    Wang, Jian Z.
    Huang, Zhibin
    Cardenes, Higinia R.
    DISCOVERY MEDICINE, 2010, 9 (48) : 404 - 410
  • [27] Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
    Wahl, Daniel R.
    Stenmark, Matthew H.
    Tao, Yebin
    Pollom, Erqi L.
    Caoili, Elaine M.
    Lawrence, Theodore S.
    Schipper, Matthew J.
    Feng, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 452 - +
  • [28] Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis
    Pan, Yang-Xun
    Fu, Yi-Zhen
    Hu, Dan-Dan
    Long, Qian
    Wang, Jun-Cheng
    Xi, Mian
    Liu, Shi-Liang
    Xu, Li
    Liu, Meng-Zhong
    Chen, Min-Shan
    Zhang, Yao-Jun
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [29] Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?
    Kumar, Ashish
    JOURNAL OF HEPATOLOGY, 2020, 73 (02) : 467 - 468
  • [30] Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: No Way Out Without a Randomized Trial?
    Fiorentino, Alba
    Alongi, Filippo
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) : 2558 - +
12345